[Inflammatory myopathies].
Primary myositis (or inflammatory myopathies) comprises three main groups of diseases, based on clinical and immunohistochemical characteristics: polymyositis (PM), dermatomyositis (DM) and inclusion body myositis. Their clinical presentation and course are disparate, but a common characteristic is immune dysfunction-related inflammation of the striated muscles. Their etiologies are still not fully elucidated but associate environmental and, to a lesser degree, genetic factors. Nevertheless, considerable progress has recently been made in the understanding and management of these diseases.
Service de médecine interne (Pr Herson) CHU La Pitié-La Salpêtrière 75651 Paris. patrick.cherin@psl.ap-hop-paris.fr
P
P
Cherin
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D003882:Dermatomyositis / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D018979:Myositis, Inclusion Body / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D010956:Plasmapheresis; D017285:Polymyositis / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D011379:Prognosis; D013256:Steroids
D000893:Anti-Inflammatory Agents; D013256:Steroids